Total Payments
$131,277
2024 Payments
$569.72
Companies
19
Transactions
379
Medicare Patients
5,422
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$110,553 (84.2%)
Travel$10,354 (7.9%)
Food & Beverage$6,401 (4.9%)
Consulting$3,900 (3.0%)
Gifts$59.40 (0.0%)
Education$8.73 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,553 | 81 | 84.2% |
| Travel and Lodging | $10,354 | 18 | 7.9% |
| Food and Beverage | $6,401 | 271 | 4.9% |
| Consulting Fee | $3,900 | 5 | 3.0% |
| Gift | $59.40 | 1 | 0.0% |
| Education | $8.73 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $71,504 | 133 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51,365 | 132 | $0 (2021) |
| Lilly USA, LLC | $5,694 | 21 | $0 (2024) |
| Novo Nordisk Inc | $608.66 | 25 | $0 (2023) |
| Amgen Inc. | $466.40 | 5 | $0 (2024) |
| Esperion Therapeutics, Inc. | $432.65 | 27 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $338.99 | 17 | $0 (2021) |
| BETA BIONICS, INC. | $279.50 | 2 | $0 (2024) |
| Abbott Laboratories | $190.07 | 4 | $0 (2022) |
| Dexcom, Inc. | $149.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $569.72 | 5 | BETA BIONICS, INC. ($279.50) |
| 2023 | $393.68 | 10 | Lilly USA, LLC ($162.39) |
| 2022 | $213.64 | 3 | Lilly USA, LLC ($125.00) |
| 2021 | $25,291 | 50 | SANOFI-AVENTIS U.S. LLC ($21,921) |
| 2020 | $6,594 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,415) |
| 2019 | $23,525 | 69 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,197) |
| 2018 | $28,355 | 90 | SANOFI-AVENTIS U.S. LLC ($19,462) |
| 2017 | $46,334 | 116 | Boehringer Ingelheim Pharmaceuticals, Inc. ($24,511) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $149.70 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 07/12/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $154.50 | General |
| Category: Automated insulin delivery system | ||||||
| 07/12/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Automated insulin delivery system | ||||||
| 02/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 11/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 10/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Diabetes | ||||||
| 09/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Diabetes | ||||||
| 04/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $102.07 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $64.61 | General |
| Category: Bone Health | ||||||
| 02/28/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $64.61 | General |
| Category: Bone Health | ||||||
| 11/08/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 09/09/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $72.69 | General |
| Category: Diabetes Care | ||||||
| 06/22/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/13/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/06/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/06/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/05/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/05/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/04/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/28/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,366 | 16,522 | $1.3M | $421,953 |
| 2022 | 5 | 1,267 | 14,447 | $1.1M | $361,575 |
| 2021 | 7 | 1,303 | 12,717 | $1.1M | $348,049 |
| 2020 | 8 | 1,486 | 10,192 | $818,277 | $248,137 |
Total Patients
5,422
Total Services
53,878
Medicare Billing
$1.4M
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 144 | 14,580 | $656,100 | $268,598 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 801 | 1,368 | $469,224 | $121,635 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 192 | 192 | $100,032 | $23,627 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 63 | $14,742 | $4,356 | 29.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 150 | 292 | $21,900 | $3,480 | 15.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 27 | $1,647 | $257.04 | 15.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 138 | 12,660 | $551,280 | $215,371 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 756 | 1,307 | $435,231 | $117,152 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 195 | 195 | $98,670 | $23,645 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 145 | 248 | $18,352 | $2,972 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 37 | $8,399 | $2,436 | 29.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 112 | 10,740 | $451,080 | $176,285 | 39.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 760 | 1,453 | $469,319 | $136,860 | 29.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 215 | 215 | $105,565 | $27,175 | 25.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 94 | $20,680 | $4,525 | 21.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 111 | 178 | $13,172 | $2,140 | 16.2% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2021 | 11 | 19 | $3,021 | $889.13 | 29.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 18 | $1,044 | $174.78 | 16.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 90 | 8,400 | $352,800 | $129,989 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 592 | 803 | $248,127 | $58,317 | 23.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 441 | 571 | $118,768 | $33,997 | 28.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 176 | 176 | $82,720 | $20,825 | 25.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 54 | 56 | $2,688 | $2,058 | 76.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 96 | 148 | $10,656 | $1,795 | 16.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 16 | $1,264 | $943.95 | 74.7% |
About Dr. Wen Han, M.D
Dr. Wen Han, M.D is a Internal Medicine healthcare provider based in Modesto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104020312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wen Han, M.D has received a total of $131,277 in payments from pharmaceutical and medical device companies, with $569.72 received in 2024. These payments were reported across 379 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($110,553).
As a Medicare-enrolled provider, Han has provided services to 5,422 Medicare beneficiaries, totaling 53,878 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Modesto, CA
- Active Since 06/12/2007
- Last Updated 08/01/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104020312
Products in Payments
- JARDIANCE (Drug) $56,388
- SOLIQUA (Drug) $22,970
- TOUJEO (Drug) $16,575
- TOUJEO (Biological) $12,319
- SOLIQUA 100/33 (Biological) $11,888
- SOLIQUA 100/33 (Drug) $7,749
- FARXIGA (Drug) $315.21
- NEXLETOL (Drug) $307.65
- MOUNJARO (Drug) $302.91
- EVENITY (Biological) $302.79
- iLet Bionic Pancreas (Device) $279.50
- Ozempic (Drug) $239.94
- Victoza (Drug) $183.30
- Prolia (Biological) $163.61
- DEXCOM G7 GSS (161) (Medical Supply) $149.70
- NEXLIZET (Drug) $125.00
- Rybelsus (Drug) $102.07
- TRADJENTA (Drug) $96.01
- FreeStyle Libre Pro (Device) $84.90
- FREESTYLE LIBRE (Device) $72.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Modesto
Robert Tanaka, M.d, M.D
Internal Medicine — Payments: $42,946
Internal Medicine $42,946
Dat Do, M.d, M.D
Internal Medicine — Payments: $23,083
Internal Medicine $23,083
Dr. Talwinderdeep Kahlon, M.d, M.D
Internal Medicine — Payments: $13,710
Internal Medicine $13,710
Dr. Priti Modi, M.d., F.a.c.p, M.D., F.A.C.P
Internal Medicine — Payments: $10,257
Internal Medicine $10,257
Lily Park, D.o, D.O
Internal Medicine — Payments: $9,808
Internal Medicine $9,808
Prithvi Shankar, Md, MD
Internal Medicine — Payments: $9,701
Internal Medicine $9,701